M. Belvisi

发表

Bradykinin–evoked sensitization of airway sensory nerves: A mechanism for ACE–inhibitor cough

K. Chung, U. Lalloo, P. Barnes, 1996, Nature Medicine.

Co-ordinated Role of TLR3, RIG-I and MDA5 in the Innate Response to Rhinovirus in Bronchial Epithelium

S. Johnston, M. Belvisi, T. Fujita, 2010, PLoS pathogens.

Targeting TRP channels for chronic cough: from bench to bedside

J. Smith, M. Belvisi, S. Bonvini, 2015, Naunyn-Schmiedeberg's Archives of Pharmacology.

Modulation of sensory nerve function and the cough reflex: understanding disease pathogenesis.

M. Belvisi, J. Nasra, 2009, Pharmacology & therapeutics.

JAK–STAT pathway activation in COPD

M. Belvisi, M. Birrell, Liang Yew-Booth, 2015, European Respiratory Journal.

Modelling the asthma phenotype: impact of cigarette smoke exposure

M. Belvisi, M. Birrell, Katie E. Baker, 2018, Respiratory Research.

Barriers to new drug development in respiratory disease

Peter J. Barnes, Brian Ward, S. Bonini, 2015 .

Barriers to new drug development in respiratory disease

S. Bonini, W. Seeger, P. Barnes, 2015, European Respiratory Journal.

Liver X Receptor Agonists Increase Airway Reactivity in a Model of Asthma via Increasing Airway Smooth Muscle Growth1

T. Willson, M. Belvisi, S. Farrow, 2008, The Journal of Immunology.

Increasing Airway Smooth Muscle Growth Reactivity in a Model of Asthma via Liver X Receptor Agonists Increase Airway

T. Willson, M. Belvisi, S. Farrow, 2008 .

Novel Role for the Liver X Nuclear Receptor in the Suppression of Lung Inflammatory Responses*

T. Willson, M. Belvisi, S. Farrow, 2007, Journal of Biological Chemistry.

differences in COPD and relationship to emphysema helium-3 and xenon-129 magnetic resonance imaging: Pulmonary ventilation visualized using hyperpolarized

D. Shaw, H. Coxson, G. Parraga, 2015 .

Neuroregulation by vasoactive intestinal peptide (VIP) of mucus secretion in ferret trachea: activation of BKCa channels and inhibition of neurotransmitter release

M. Belvisi, D. Rogers, Yu‐Chih Liu, 1999, British journal of pharmacology.

Role of EP2 and EP4 receptors in airway microvascular leak induced by prostaglandin E2

Stephen R. Clark, M. Belvisi, V. O’Donnell, 2016, British journal of pharmacology.

Expert opinion on the cough hypersensitivity syndrome in respiratory medicine

S. Birring, J. Smith, A. Morice, 2014, European Respiratory Journal.

Prostanoid receptor expression by human airway smooth muscle cells and regulation of the secretion of granulocyte colony-stimulating factor.

M. Yacoub, M. Belvisi, Susan J. Smith, 2005, American journal of physiology. Lung cellular and molecular physiology.

Induction of cyclo‐oxygenase‐2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type

M. Yacoub, J. Mitchell, P. Barnes, 1997, British journal of pharmacology.

Release of granulocyte‐macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone

M. Yacoub, J. Mitchell, P. Barnes, 1997, British journal of pharmacology.

Effect of the p38 kinase inhibitor, SB 203580, on allergic airway inflammation in the rat

M. Belvisi, M. Birrell, M. Foster, 2000, British journal of pharmacology.

Effect of dopamine receptor agonists on sensory nerve activity: possible therapeutic targets for the treatment of asthma and COPD

M. Yacoub, P. Barnes, M. Belvisi, 2002, British journal of pharmacology.

Effects of aerobic exercise on molecular aspects of asthma: involvement of SOCS-JAK-STAT.

M. Belvisi, R. Vieira, N. R. Damaceno‐Rodrigues, 2019, Exercise immunology review.

Capsazepine as a selective antagonist of capsaicin-induced activation of C-fibres in guinea-pig bronchi.

P. Barnes, M. Belvisi, M. Miura, 1992, European journal of pharmacology.

Neurogenic inflammation in the airways: characterisation of electrical parameters for vagus nerve stimulation in the guinea pig

P. Barnes, M. Belvisi, D. Rogers, 1990, Journal of Neuroscience Methods.

Pulmonary Disease Therapy Relevance for Chronic Obstructive Corticosteroids: Anti-inflammatory Profile to Airway Smooth Muscle Cells Has a Superior Proliferator-Activated Receptors in Human Activation of Peroxisome

M. Yacoub, J. Mitchell, M. Belvisi, 2013 .

Activation of Peroxisome Proliferator-Activated Receptors in Human Airway Smooth Muscle Cells Has a Superior Anti-inflammatory Profile to Corticosteroids: Relevance for Chronic Obstructive Pulmonary Disease Therapy 1

M. Yacoub, J. Mitchell, M. Belvisi, 2003, The Journal of Immunology.

Tiotropium modulates transient receptor potential V1 (TRPV1) in airway sensory nerves: A beneficial off-target effect?⋆☆

M. Belvisi, S. Bonvini, M. Birrell, 2014, The Journal of allergy and clinical immunology.

Release of nerve growth factor by human pulmonary epithelial cells: role in airway inflammatory diseases.

P. Barnes, A. Fox, M. Belvisi, 2001, European journal of pharmacology.

New Advances and Potential Therapies for the Treatment of Asthma

M. Belvisi, M. Birrell, D. Hele, 2012, BioDrugs.

Novel therapies for the treatment of inflammatory airway disease

M. Belvisi, D. Hele, 2003, Expert opinion on investigational drugs.

afferent neurons in the antitussive effects of menthol The role of trigeminal nasal TRPM8-expressing

S. Birring, J. Smith, A. Morice, 2015 .

Critical Role for T Cells in Sephadex-Induced Airway Inflammation: Pharmacological and Immunological Characterization and Molecular Biomarker Identification

C. Battram, M. Belvisi, M. Birrell, 2002, The Journal of Immunology.

Molecular Biomarker Identification Immunological Characterization and Airway Inflammation: Pharmacological and Critical Role for T Cells in Sephadex-Induced

C. Battram, M. Belvisi, H. Cliff, 2002 .

Expression of cyclo‐oxygenase‐2 in human airway smooth muscle is associated with profound reductions in cell growth

M. Yacoub, M. Belvisi, M. Yacoub, 1998, British journal of pharmacology.

Prostaglandin E2 mediates cough via the EP3 receptor: implications for future disease therapy.

M. Belvisi, M. Birrell, Sarah A. Maher, 2009, American journal of respiratory and critical care medicine.

EP4 receptor as a new target for bronchodilator therapy

M. Belvisi, D. Clarke, M. Birrell, 2011, Thorax.

Paradoxical facilitation of acetylcholine release from parasympathetic nerves innervating guinea‐pig trachea by isoprenaline

P. Barnes, M. Belvisi, M. Giembycz, 1996, British journal of pharmacology.

Evidence for the involvement of cGMP in neural bronchodilator responses in humal trachea.

M. Yacoub, P. Barnes, M. Belvisi, 1995, The Journal of physiology.

Modulation of the TRPV4 ion channel as a therapeutic target for disease.

P. McIntyre, M. Belvisi, S. Bonvini, 2017, Pharmacology & therapeutics.

8-Epi-PGF2 alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro.

M. Yacoub, P. Barnes, M. Belvisi, 1996, American journal of respiratory and critical care medicine.

E‐Ring 8‐isoprostanes inhibit ACh release from parasympathetic nerves innervating guinea‐pig trachea through agonism of prostanoid receptors of the EP3‐subtype

M. Belvisi, D. Clarke, M. Giembycz, 2004, British journal of pharmacology.

Impact of tobacco‐smoke on key signaling pathways in the innate immune response in lung macrophages

M. Belvisi, M. Birrell, M. Catley, 2008, Journal of cellular physiology.

Advances in TRP channel drug discovery: from target validation to clinical studies

M. Belvisi, R. Gaudet, A. Szallasi, 2021, Nature Reviews Drug Discovery.

Mechanistic link between diesel exhaust particles and respiratory reflexes

M. Belvisi, M. Shaffer, T. Tetley, 2017, The Journal of allergy and clinical immunology.

TRPA1 is activated by direct addition of cysteine residues to the N-hydroxysuccinyl esters of acrylic and cinnamic acids.

Laura R. Sadofsky, A. Morice, M. Belvisi, 2011, Pharmacological research.

The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD

J. Smith, Dave Singh, M. Belvisi, 2021, European Respiratory Journal.

New anti-inflammatory therapies and targets for asthma and chronic obstructive pulmonary disease

M. Belvisi, M. Birrell, D. Hele, 2004, Expert opinion on therapeutic targets.

Occasional review Nitric oxide andlungdisease

M. Belvisi, Peter Jbarnes, 1993 .

Lung-resident eosinophils represent a distinct regulatory eosinophil subset.

M. Thiry, M. Belvisi, K. Thielemans, 2016, The Journal of clinical investigation.

MMP/TIMP expression profiles in distinct lung disease models: implications for possible future therapies

M. Belvisi, M. Birrell, Sissie Wong, 2009, Respiratory research.

The role of MMPs in the inflammatory process of acute lung injury

M. Belvisi, M. Birrell, Sissie Wong, 2008 .

Role of the ion channel, transient receptor potential cation channel subfamily V member 1 (TRPV1), in allergic asthma

M. Belvisi, M. Birrell, Katie E. Baker, 2016, Respiratory Research.

Bronchodilator activity of bitter tastants in human tissue

M. Belvisi, B. Canning, M. Birrell, 2011, Nature Medicine.

A role for sensory nerves in the late asthmatic response

P. O'Byrne, J. Fozard, M. Belvisi, 2011, Thorax.

Neuropeptides in the respiratory tract. Part I.

P. Barnes, M. Belvisi, J. Baraniuk, 1991, The American review of respiratory disease.

Inhibitory activity of the novel CB2 receptor agonist, GW833972A, on guinea‐pig and human sensory nerve function in the airways

M. Belvisi, M. Birrell, V. Freund-Michel, 2008, British journal of pharmacology.

Inhibitory NANC nerves in human tracheal smooth muscle: a quest for the neurotransmitter.

G. Verleden, M. Yacoub, P. Barnes, 1992, Journal of applied physiology.

Modulation of cholinergic neural bronchoconstriction by endogenous nitric oxide and vasoactive intestinal peptide in human airways in vitro.

M. Yacoub, P. Barnes, A. Fox, 1993, The Journal of clinical investigation.

Cough sensors. III. Opioid and cannabinoid receptors on vagal sensory nerves.

M. Belvisi, D. Hele, 2009, Handbook of experimental pharmacology.

Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF‐κB‐independent mechanism

M. Belvisi, L. Donnelly, M. Birrell, 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Induction of cyclo‐oxygenase‐2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone

J. Vane, J. Mitchell, P. Barnes, 1994, British journal of pharmacology.

DNA damage response at telomeres contributes to lung aging and chronic obstructive pulmonary disease.

M. Belvisi, Clara Correia-Melo, M. Birrell, 2015 .

DNA damage response at telomeres contributes to lung aging and chronic obstructive pulmonary disease

M. Belvisi, Clara Correia-Melo, M. Birrell, 2015, American journal of physiology. Lung cellular and molecular physiology.

Preclinical animal models of asthma and chronic obstructive pulmonary disease

Christopher S. Stevenson, C. Stevenson, M. Belvisi, 2008, Expert review of respiratory medicine.

Capsazepine inhibits cough induced by capsaicin and citric acid but not by hypertonic saline in guinea pigs.

K. Chung, U. Lalloo, P. Barnes, 1995, Journal of applied physiology.

Evidence that the anti‐spasmogenic effect of the β‐adrenoceptor agonist, isoprenaline, on guinea‐pig trachealis is not mediated by cyclic AMP‐dependent protein kinase

P. Barnes, M. Belvisi, M. Birrell, 2001, British journal of pharmacology.

G-protein coupled receptors regulating cough.

M. Belvisi, E. Dubuis, Sarah A. Maher, 2011, Current opinion in pharmacology.

Modulation of neurotransmission in guinea-pig airways by galanin and the effect of a new antagonist galantide

P. Barnes, M. Belvisi, T. Takahashi, 1994, Neuropeptides.

Cholinergic control of human airways in vitro following extrinsic denervation of the human respiratory tract by heart-lung transplantation.

M. Yacoub, P. Barnes, M. Belvisi, 1990, The American review of respiratory disease.

The heterotopic tracheal allograft as an animal model of obliterative bronchiolitis

M. Yacoub, M. Belvisi, D. Hele, 2001, Respiratory research.

Effects of Neuropeptides on Neurotransmission in the Airways

M. Belvisi, 2017 .

Localization of beta pre-protachykinin mRNA in nodose ganglion

P. Barnes, M. Belvisi, A. Harmar, 1991, Neuropeptides.

Albuterol-induced downregulation of Gsα accounts for pulmonary β2-adrenoceptor desensitization in vivo

C. Scorer, I. Adcock, P. Barnes, 2000 .

Albuterol-induced downregulation of Gsalpha accounts for pulmonary beta(2)-adrenoceptor desensitization in vivo.

C. Scorer, I. Adcock, P. Barnes, 2000, The Journal of clinical investigation.

Defining critical roles for NF-κB p65 and type I interferon in innate immunity to rhinovirus

S. Johnston, S. Kotenko, M. Belvisi, 2012, EMBO molecular medicine.

ATP and cough reflex hypersensitivity: a confusion of goals?

J. Smith, M. Belvisi, 2017, European Respiratory Journal.

Cough hypersensitivity syndrome: clinical measurement is the key to progress

S. Birring, J. Smith, A. Morice, 2015, European Respiratory Journal.

TRPA1 agonists evoke coughing in guinea pig and human volunteers.

Laura R. Sadofsky, A. Morice, M. Belvisi, 2009, American journal of respiratory and critical care medicine.

Neurophenotypes in Airway Diseases. Insights from Translational Cough Studies.

J. Smith, A. Woodcock, M. Belvisi, 2016, American journal of respiratory and critical care medicine.

Cromoglycate: Breathing life into an old asthma drug

P. Barnes, M. Belvisi, S. Bonvini, 2015 .

KININS AND NEUROPEPTIDES | Other Important Neuropeptides

M. Belvisi, D. Hele, 2006 .

Neuropeptide Y modulates non-adrenergic, non-cholinergic neural bronchoconstriction in vivo and in vitro

P. Barnes, M. Belvisi, C. Stretton, 1989, Neuropeptides.

Correction: Cigarette Smoke Induced Airway Inflammation Is Independent of NF-κB Signalling

Christopher S. Stevenson, I. Adcock, T. Lawrence, 2013, PLoS ONE.

E-Ring 8-Isoprostanes Are Agonists at EP2- and EP4-Prostanoid Receptors on Human Airway Smooth Muscle Cells and Regulate the Release of Colony-Stimulating Factors by Activating cAMP-Dependent Protein Kinase

M. Belvisi, D. Clarke, R. Newton, 2005, Molecular Pharmacology.

Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM‐CSF

M. Yacoub, M. Belvisi, D. Clarke, 2004, British journal of pharmacology.

RANTES release by human airway smooth muscle: effects of prostaglandin E(2) and fenoterol.

M. Yacoub, N. Lazzeri, K. Chung, 2001, European journal of pharmacology.

Effects of Prostaglandin E2 and cAMP Elevating Drugs on GM-CSF Release by Cultured Human Airway Smooth Muscle Cells

M. Yacoub, N. Lazzeri, K. Chung, 2001 .

Effects of prostaglandin E2 and cAMP elevating drugs on GM-CSF release by cultured human airway smooth muscle cells. Relevance to asthma therapy.

M. Yacoub, N. Lazzeri, K. Chung, 2001, American journal of respiratory cell and molecular biology.

Prostaglandin D2 and the role of the DP1, DP2 and TP receptors in the control of airway reflex events

M. Belvisi, S. Bonvini, M. Birrell, 2014, European Respiratory Journal.

Transient receptor potential channels mediate the tussive response to prostaglandin E2 and bradykinin

M. Belvisi, M. Birrell, E. Dubuis, 2012, Thorax.

TRPA1 receptors in cough.

M. Belvisi, M. Grace, 2011, Pulmonary pharmacology & therapeutics.

Transient Receptor Potential A1 Channels Insights Into Cough and Airway Inﬂ ammatory Disease

M. Belvisi, M. Birrell, E. Dubuis, 2011 .

β2-Agonists block tussive responses in guinea pigs via an atypical cAMP-dependent pathway

M. Belvisi, M. Birrell, M. Giembycz, 2009, European Respiratory Journal.

Preclinical Assessment of Novel Therapeutics on the Cough Reflex: Cannabinoid Agonists as Potential Antitussives

M. Belvisi, 2007, Lung.

Cough: Citric acid and nerves

M. Belvisi, D. Hele, 2006 .

Inhibition of guinea‐pig and human sensory nerve activity and the cough reflex in guinea‐pigs by cannabinoid (CB2) receptor activation

M. Yacoub, P. Barnes, M. Belvisi, 2003, British journal of pharmacology.

Activation of large conductance potassium channels inhibits the afferent and efferent function of airway sensory nerves in the guinea pig.

P. Barnes, A. Fox, M. Belvisi, 1997, The Journal of clinical investigation.

Transient receptor potential channels mediate the tussive response to prostaglandin E2 and bradykinin

M. Belvisi, M. Birrell, E. Dubuis, 2012, Thorax.

Nitric oxide synthase activity is elevated in inflammatory lung disease in humans.

M. Belvisi, J. Mitchell, S. Tadjkarimi, 1995, European journal of pharmacology.

Effect of bradykinin on airway neural responses in vitro.

P. Barnes, M. Belvisi, M. Miura, 1992, Journal of applied physiology.

Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease.

P. Barnes, M. Belvisi, J. Mak, 1995, Life sciences.

The effect of sensory nerve depletion on cholinergic neurotransmission in guinea-pig airways.

P. Barnes, M. Belvisi, C. Stretton, 1989, British journal of pharmacology.

Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of Asthma

L. Rönnblom, A. Laurence, D. Zervas, 2022, Drug design, development and therapy.

DDDT_A_354291 2901..2917

L. Rönnblom, A. Laurence, D. Zervas, 2022 .

Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea‐pig airways

M. Yacoub, P. Barnes, M. Belvisi, 1999, British journal of pharmacology.

Characterisation of pharmacokinetics, safety and tolerability in a first‐in‐human study for AZD8154, a novel inhaled selective PI3Kγδ dual inhibitor targeting airway inflammatory disease

M. Belvisi, S. Nemes, C. Keen, 2021, British journal of clinical pharmacology.

New Glucocorticosteroids with an improved therapeutic ratio?

M. Belvisi, M. Foster, T. Brown, 2001, Pulmonary pharmacology & therapeutics.

Therapeutic Benefit of a Dissociated Glucocorticoid and the Relevance of In Vitro Separation of Transrepression from Transactivation Activity

C. Battram, M. Belvisi, T. Brown, 2001, The Journal of Immunology.

Chronic systemic administration of salmeterol to rats promotes pulmonary β2‐adrenoceptor desensitization and down‐regulation of Gsα

C. Scorer, P. Barnes, M. Belvisi, 2001 .

Mechanisms of prostaglandin E2 release by intact cells expressing cyclooxygenase-2: evidence for a 'two-component' model.

P. Barnes, M. Belvisi, T. Warner, 1999, The Journal of pharmacology and experimental therapeutics.

Too many COX ( cyclooxygenase cyclooxygenase cyclooxygenase ) spoil the broth : aspirinsensitive aspirinsensitive aspirinsensitive asthma and 5lipoxygenase 5lipoxygenase 5lipoxygenase

J. Mitchell, M. Belvisi, 1998 .

Too many COX (cyclo-oxygenase) spoil the broth: aspirin-sensitive asthma and 5-lypoxygenase.

M. Belvisi, J. Mitchell, 1997, Thorax.

Bradykinin-induced bronchoconstriction in guinea pig in vivo: role of neural mechanisms.

P. Barnes, M. Belvisi, M. Ichinose, 1990, The Journal of pharmacology and experimental therapeutics.

Induction of eotaxin expression and release from human airway smooth muscle cells by IL-1beta and TNFalpha: effects of IL-10 and corticosteroids.

K. Chung, M. Belvisi, P. Jose, 1999, British journal of pharmacology.

Estrogen Receptor β: Expression Profile and Possible Anti-Inflammatory Role in Disease

M. Belvisi, S. Farrow, M. Birrell, 2008, Journal of Pharmacology and Experimental Therapeutics.

Nedocromil sodium modulates nonadrenergic, noncholinergic bronchoconstrictor nerves in guinea pig airways in vitro.

G. Verleden, P. Barnes, M. Belvisi, 1991, The American review of respiratory disease.

Mediator involvement in antigen‐induced bronchospasm and microvascular leakage in the airways of ovalbumin sensitized Brown Norway rats

M. Belvisi, M. Birrell, M. Foster, 2001, British journal of pharmacology.

Differential Effects of Ebselen on Neutrophil Recruitment, Chemokine, and Inflammatory Mediator Expression in a Rat Model of Lipopolysaccharide-Induced Pulmonary Inflammation

M. Belvisi, M. Birrell, G. T. De Sanctis, 2002, The Journal of Immunology.

Functional characterization and biomarker identification in the Brown Norway model of allergic airway inflammation

M. Belvisi, M. Birrell, M. Foster, 2002, British journal of pharmacology.

Summary: animal models for cough.

M. Belvisi, D. Bolser, 2002, Pulmonary pharmacology & therapeutics.

Theophylline inhibits the cough reflex through a novel mechanism of action☆

M. Belvisi, M. Birrell, E. Dubuis, 2014, The Journal of allergy and clinical immunology.

Endogenous vasoactive intestinal peptide and nitric oxide modulate cholinergic neurotransmission in guinea-pig trachea.

P. Barnes, M. Belvisi, M. Miura, 1993, European journal of pharmacology.

On Line Supplement Trp Channels Mediate the Tussive Response to Prostaglandin E 2 and Bradykinin

M. Belvisi, M. Birrell, E. Dubuis, 2022 .

Prostaglandin E2 suppression of acetylcholine release from parasympathetic nerves innervating guinea‐pig trachea by interacting with prostanoid receptors of the EP3‐subtype

M. Belvisi, M. Giembycz, L. Spicuzza, 1998, British journal of pharmacology.

Effect of endothelin antagonists, including the novel ETA receptor antagonist LBL 031, on endothelin‐1 and lipopolysaccharide‐induced microvascular leakage in rat airways

M. Belvisi, M. Birrell, M. Foster, 2000, British journal of pharmacology.

Characterization of the effects of cannabinoids on guinea‐pig tracheal smooth muscle tone: role in the modulation of acetylcholine release from parasympathetic nerves

M. Belvisi, D. Clarke, M. Birrell, 2000, British journal of pharmacology.

Antigen-induced bronchial hyperresponsiveness in the rabbit is not dependent on M(2)-receptor dysfunction.

P. Barnes, M. Belvisi, C. Page, 1999, Pulmonary pharmacology & therapeutics.

Modulation of acetylcholine release from parasympathetic nerves innervating guinea-pig and human trachea by endomorphin-1 and -2.

M. Yacoub, P. Barnes, A. Fox, 1999, European journal of pharmacology.

Inhibition of cholinergic neurotransmission in guinea pig trachea by NS1619, a putative activator of large-conductance, calcium-activated potassium channels.

P. Barnes, M. Belvisi, M. Giembycz, 1998, The Journal of pharmacology and experimental therapeutics.

Evidence for prejunctional muscarinic autoreceptors in human and guinea pig trachea.

M. Yacoub, P. Barnes, M. Belvisi, 1995, American journal of respiratory and critical care medicine.

Effect of Ba 679 BR, a novel long-acting anticholinergic agent, on cholinergic neurotransmission in guinea pig and human airways.

M. Yacoub, P. Barnes, M. Belvisi, 1994, American journal of respiratory and critical care medicine.

High Levels of Nitric Oxide Synthase Activity are Associated with Nasal Polyp Tissue from Aspirin-sensitive Asthmatics

G. Scadding, M. Belvisi, J. Mitchell, 2002, Acta oto-laryngologica.

Harvesting, Isolation, and Functional Assessment of Primary Vagal Ganglia Cells

M. Belvisi, M. Birrell, E. Dubuis, 2013, Current protocols in pharmacology.

Calcium-activated potassium channels mediate prejunctional inhibition of peripheral sensory nerves.

P. Barnes, M. Belvisi, M. Miura, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Modulation of neurogenic inflammation: novel approaches to inflammatory disease.

P. Barnes, M. Belvisi, D. Rogers, 1990, Trends in pharmacological sciences.

The role of adenylyl cyclase isoform 6 in β‐adrenoceptor signalling in murine airways

M. Belvisi, S. Bonvini, M. Birrell, 2015, British journal of pharmacology.

Bronchodilating effects of the novel potassium channel opener HOE 234 in human airways in vitro.

M. Yacoub, P. Barnes, M. Belvisi, 1993, British Journal of Clinical Pharmacology.

Role of potassium channels in bronchodilator responses in human airways.

M. Yacoub, P. Barnes, M. Belvisi, 1992, The American review of respiratory disease.

Modulation of non‐adrenergic, non‐cholinergic neural bronchoconstriction in guinea‐pig airways via GABAB‐receptors

P. Barnes, M. Belvisi, M. Ichinose, 1989, British journal of pharmacology.

Modulation of neural bronchoconstrictor responses in the guinea pig respiratory tract by vasoactive intestinal peptide

P. Barnes, M. Belvisi, C. Stretton, 1991, Neuropeptides.

The role of CRAC channel in asthma.

Dave Singh, M. Belvisi, M. Birrell, 2015, Pulmonary pharmacology & therapeutics.

Naloxone‐insensitive inhibition of acetylcholine release from parasympathetic nerves innervating guinea‐pig trachea by the novel opioid, nociceptin

M. Belvisi, M. Giembycz, L. Spicuzza, 1997, British journal of pharmacology.

Inhibition of cholinergic neurotransmission in human airways by opioids.

G. Verleden, M. Yacoub, P. Barnes, 1992, Journal of applied physiology.

Modulation of cholinergic neurotransmission in guinea‐pig airways by opioids

P. Barnes, M. Belvisi, P. Barnes, 1990, British journal of pharmacology.

Preclinical Profile of Ciclesonide, a Novel Corticosteroid for the Treatment of Asthma

C. Battram, M. Belvisi, D. Bundschuh, 2005, Journal of Pharmacology and Experimental Therapeutics.

Beta 2-adrenoceptor agonists inhibit NANC neural bronchoconstrictor responses in vitro.

G. Verleden, K. Rabe, P. Barnes, 1993, Journal of applied physiology.

Muscarinic and beta-adrenergic receptor expression in peripheral lung from normal and asthmatic patients.

P. Barnes, M. Belvisi, J. Mak, 1996, The American journal of physiology.

Downregulation of MicroRNA‐126 Augments DNA Damage Response in Cigarette Smokers and Patients with Chronic Obstructive Pulmonary Disease

M. Mayr, A. Zampetaki, P. Barnes, 2018, American journal of respiratory and critical care medicine.

Effect of 8-iso-prostaglandin F2α on acetylcholine release from parasympathetic nerves in guinea pig airways

P. Barnes, M. Belvisi, L. Spicuzza, 2001 .

Facilitatory effects of selective agonists for tachykinin receptors on cholinergic neurotransmission: evidence for species differences

P. Barnes, M. Belvisi, C. Maggi, 1994, British journal of pharmacology.

Neurogenic inflammation in the airways: Measurement of microvascular leakage

M. Belvisi, D. Rogers, 1998 .

Neurogenic plasma extravasation: inhibition by morphine in guinea pig airways in vivo.

P. Barnes, M. Belvisi, D. Rogers, 1989, Journal of applied physiology.

Opioid modulation of non‐cholinergic neural bronchoconstriction in guinea‐pig in vivo

K. Chung, D. Jackson, P. Barnes, 1988, British journal of pharmacology.

Opioid modulation ofnon-cholinergic neural bronchoconstriction inguinea-pig invivo

K. Chung, P. Barnes, M. Belvisi, 1988 .

Exercise Inhibits the Effects of Smoke-Induced COPD Involving Modulation of STAT3

M. Belvisi, A. Bachi, A. Abbasi, 2017, Oxidative Medicine and Cellular Longevity.

Exercise Inhibits the Effects of Smoke-Induced COPD Involving Modulation of STAT 3 Maysa

M. Belvisi, R. Vieira, A. Bachi, 2017 .

Second-Generation Inhibitors Demonstrate the Involvement of p38 Mitogen-Activated Protein Kinase in Post-Transcriptional Modulation of Inflammatory Mediator Production in Human and Rodent Airways

M. Belvisi, M. Birrell, S. Haj‐Yahia, 2006, Journal of Pharmacology and Experimental Therapeutics.

Prostanoids and the Cough Reflex

M. Belvisi, Sarah A. Maher, S. Maher, 2009, Lung.

Role of K+ channels in the modulation of cholinergic neural responses in guinea‐pig and human airways.

M. Yacoub, P. Barnes, M. Belvisi, 1992, The Journal of physiology.

Pharmacological Assessment of the Nitric-Oxide Synthase Isoform Involved in Eosinophilic Inflammation in a Rat Model of Sephadex-Induced Airway Inflammation

M. Yacoub, C. Battram, M. Belvisi, 2003, Journal of Pharmacology and Experimental Therapeutics.

Neuropeptides in the respiratory tract. Part II.

P. Barnes, M. Belvisi, J. Baraniuk, 1991, The American review of respiratory disease.

β‐blocker induced asthma: a role for sensory nerve hyperresponsiveness?

M. Belvisi, 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Histamine H3-receptors inhibit neurogenic microvascular leakage in airways.

P. Barnes, M. Belvisi, M. Ichinose, 1990, Journal of applied physiology.

The ever-expanding ERS fellowship programmes: achievements over the past 3 years

S. Holgate, M. Miravitlles, M. Belvisi, 2016, European Respiratory Journal.

Inhibition of excitatory non‐adrenergic non‐cholinergic bronchoconstriction in guinea‐pig airways in vitro by activation of an atypical 5‐HT receptor

A. Fox, M. Belvisi, J. Ward, 1994, British journal of pharmacology.

The TRPV4 ion channel plays a key role in allergic asthma

M. Belvisi, G. Tarrasón, S. Bonvini, 2016 .

Aprepitant For Cough in Lung Cancer: A Randomised Placebo-Controlled Trial and Mechanistic Insights.

J. Smith, A. Molassiotis, M. Belvisi, 2020, American journal of respiratory and critical care medicine.

PPAR‐γ agonists as therapy for diseases involving airway neutrophilia

M. Belvisi, M. Birrell, M. H. Yacoub, 2004, European Respiratory Journal.

Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6.

S. Johnston, M. Belvisi, P. Wark, 2020, American journal of respiratory cell and molecular biology.

Anti-inflammatory properties of ebselen in a model of sephadex-induced lung inflammation.

C. Battram, M. Belvisi, M. Birrell, 2000, The European respiratory journal.

Dissociation by steroids of eosinophilic inflammation from airway hyperresponsiveness in murine airways

C. Battram, M. Belvisi, M. Birrell, 2003, Respiratory research.

TLR4 activation induces IL-1β release via an IPAF dependent but caspase 1/11/8 independent pathway in the lung

M. Belvisi, M. Birrell, E. Dubuis, 2014, Respiratory Research.

Effect of traffic-related air pollution on cough in adults with polymorphisms in several cough-related genes

M. Ryu, M. Belvisi, Ryan D. Huff, 2022, Respiratory Research.

This information is current as Dendritic Cells Dampens the Reactivity of 2 Prostaglandin E Bronchial Epithelial Cell-Derived

D. Tsikas, F. Lasitschka, M. Belvisi, 2011 .

Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans.

M. Yacoub, P. Barnes, M. Belvisi, 1992, European journal of pharmacology.

Targeting fatty acid amide hydrolase as a therapeutic strategy for antitussive therapy

M. Belvisi, G. McMurray, S. Bonvini, 2017, European Respiratory Journal.

Therapeutic advances for treatment-resistant cough

M. Belvisi, 2015, The Lancet.

Sensory nerve depletion potentiates inhibitory non-adrenergic, non-cholinergic nerves in guinea-pig airways.

P. Barnes, M. Belvisi, C. Stretton, 1990, European journal of pharmacology.

Selectivity profiling of the novel EP2 receptor antagonist, PF‐04418948, in functional bioassay systems: atypical affinity at the guinea pig EP2 receptor

M. Belvisi, N. Pullen, S. Bonvini, 2013, British journal of pharmacology.

Pharmacology and Therapeutics of Cough

J. Widdicombe, K. Chung, M. Belvisi, 2010 .

“Truth is ever to be found in simplicity, and not in the multiplicity and confusion of things” — Sir Isaac Newton

J. Smith, M. Belvisi, S. Bonvini, 2020, European Respiratory Journal.

Neurokinin-1 receptor antagonism for the treatment of cough in lung cancer

J. Smith, A. Molassiotis, M. Belvisi, 2016 .

Contraction of human airway smooth muscle by endothelin-1 and IRL 1620: effect of bosentan.

M. Yacoub, P. Barnes, M. Belvisi, 1997, European journal of pharmacology.

House dust mite induces direct airway inflammation in vivo: implications for future disease therapy?

Richard Graham Knowles, M. Belvisi, M. Birrell, 2009, European Respiratory Journal.

Nitric Oxide as a Noninvasive Biomarker of Lipopolysaccharide-Induced Airway Inflammation: Possible Role in Lung Neutrophilia

M. Belvisi, M. Birrell, Sissie Wong, 2004, Journal of Pharmacology and Experimental Therapeutics.

vin-induced plasma exudation in guinea-pig airways in vivo and the effect of neutrophil depletion

K. Chung, M. Belvisi, D. Rogers, 2012 .

The protective role of epithelium-derived nitric oxide in isolated bovine trachea.

M. Cazzola, M. Belvisi, M. Matera, 2002, Pulmonary pharmacology & therapeutics.

Anti-inflammatory effects of PGE2 in the lung: role of the EP4 receptor subtype

M. Belvisi, M. Birrell, Victoria C Jones, 2015, Thorax.

5-Hydroxytryptamine facilitates cholinergic bronchoconstriction in human and guinea pig airways.

M. Yacoub, P. Barnes, M. Belvisi, 1995, American journal of respiratory and critical care medicine.

Modulation of nonadrenergic noncholinergic neural bronchoconstriction by bradykinin in anesthetized guinea pigs in vivo.

P. Barnes, M. Belvisi, M. Miura, 1994, The Journal of pharmacology and experimental therapeutics.

TNFα and IFNγ Synergistically Enhance Transcriptional Activation of CXCL10 in Human Airway Smooth Muscle Cells via STAT-1, NF-κB, and the Transcriptional Coactivator CREB-binding Protein

M. Belvisi, D. Proud, A. Knox, 2010, The Journal of Biological Chemistry.

In vivo bioimaging with tissue-specific transcription factor activated luciferase reporters

M. Belvisi, T. McKay, P. Arbuthnot, 2015, Scientific Reports.

Don’t forget the nose and pulmonary circulation!

M. Belvisi, K. Broadley, 2005 .

Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroids.

K. Chung, P. Barnes, M. Belvisi, 1998, American journal of respiratory cell and molecular biology.

Novel airway smooth muscle–mast cell interactions and a role for the TRPV4-ATP axis in non-atopic asthma

M. Belvisi, P. Bradding, P. Flajolet, 2020, European Respiratory Journal.

P2X7 Receptor and Caspase 1 Activation Are Central to Airway Inflammation Observed after Exposure to Tobacco Smoke

Christopher S. Stevenson, C. Stevenson, M. Belvisi, 2011, PloS one.

Effects and interactions of sensory neuropeptides on airway microvascular leakage in guinea‐pigs

T. Evans, P. Barnes, M. Belvisi, 1988, British journal of pharmacology.

Anti‐spasmogenic activity of isoenzyme‐selective phosphodiesterase inhibitors in guinea‐pig trachealis

P. Barnes, M. Belvisi, M. Bernareggi, 1999, British journal of pharmacology.

Transactivation Activity Separation of Transrepression from Glucocorticoid and the Relevance of In Vitro Therapeutic Benefit of a Dissociated

C. Battram, M. Belvisi, S. Bottoms, 2001 .

Targeting TRP channels for chronic cough: from bench to bedside

J. Smith, M. Belvisi, S. Bonvini, 2015, Naunyn-Schmiedeberg's Archives of Pharmacology.

Animal Models of Cough

M. Belvisi, D. Hele, 2008 .

Dual action of nitric oxide on airway plasma leakage.

P. Barnes, M. Belvisi, M. Bernareggi, 1997, American journal of respiratory and critical care medicine.

Bombesin-induced bronchoconstriction in the guinea pig: mode of action.

P. Barnes, M. Belvisi, C. Stretton, 1991, The Journal of pharmacology and experimental therapeutics.

Chronic systemic administration of salmeterol to rats promotes pulmonary beta(2)-adrenoceptor desensitization and down-regulation of G(s alpha).

C. Scorer, I. Adcock, P. Barnes, 2001, British journal of pharmacology.

Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor.

M. Belvisi, A. Clark, 2012, Pharmacology & therapeutics.

Do the current house dust mite-driven models really mimic allergic asthma?

M. Belvisi, M. Birrell, A. V. van Oosterhout, 2010, European Respiratory Journal.

PPAR-gamma agonists as therapy for diseases involving airway neutrophilia.

M. Yacoub, M. Belvisi, M. Birrell, 2004, The European respiratory journal.

From the authors:

M. Belvisi, M. Birrell, V. Freund-Michel, 2009, European Respiratory Journal.

TRPV1 in the airways

P. Barnes, M. Belvisi, 2005 .

Hyperpolarized 83Kr magnetic resonance imaging of alveolar degradation in a rat model of emphysema

D. Shaw, M. Belvisi, M. Birrell, 2015, Journal of The Royal Society Interface.

Nitric oxide as an endogenous modulator of cholinergic neurotransmission in guinea-pig airways.

P. Barnes, M. Belvisi, D. Stretton, 1991, European journal of pharmacology.

Addressing unmet needs in understanding asthma mechanisms

J. Smith, P. Cullinan, J. Virchow, 2017, European Respiratory Journal.

TRP Channel Antagonists as Potential Antitussives

M. Belvisi, M. Birrell, E. Dubuis, 2012, Lung.

Targeting Alveolar Repair in Idiopathic Pulmonary Fibrosis

M. Belvisi, L. Murray, D. Wagner, 2021, American journal of respiratory cell and molecular biology.

Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids

M. Lindsay, M. Belvisi, M. Birrell, 2007, BMC Genomics.

Dysregulation of COVID-19 related gene expression in the COPD lung

R. Chaerkady, D. Muthas, A. Bornot, 2021, Respiratory Research.

Regulation of inflammatory cell function by corticosteroids.

M. Belvisi, 2004, Proceedings of the American Thoracic Society.

Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor kappaB) activation: role of arachidonic acid.

P. Barnes, M. Belvisi, R. Newton, 1997, Molecular pharmacology.

Chronic lung diseases: prospects for regeneration and repair

P. Barnes, M. Belvisi, G. Anderson, 2021, European Respiratory Review.

Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking.

Paolo Vineis, Fulvio Ricceri, Karin van Veldhoven, 2013, Human molecular genetics.

Role of the Inflammasome-Caspase1/11-IL-1/18 Axis in Cigarette Smoke Driven Airway Inflammation: An Insight into the Pathogenesis of COPD

Christopher S. Stevenson, C. Stevenson, M. Belvisi, 2014, PloS one.

Role of transient receptor potential and pannexin channels in cigarette smoke-triggered ATP release in the lung

M. Belvisi, M. Birrell, E. Dubuis, 2014, Thorax.

Targeting the NF-κB pathway in asthma and chronic obstructive pulmonary disease

S. Johnston, M. Belvisi, M. Edwards, 2008, Pharmacology & Therapeutics.

Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis

Sri V. V. Deevi, L. Wain, R. Allen, 2021, Communications biology.

Identification of a novel missense variant in SPDL1 associated with idiopathic pulmonary fibrosis

Sri V. V. Deevi, L. Wain, R. Allen, 2020, bioRxiv.

CD4+ and CD8+ T cells play a central role in a HDM driven model of allergic asthma

M. Belvisi, M. Birrell, E. Dubuis, 2016, Respiratory Research.

Ikappa-B kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma.

Robert Newton, Elizabeth Hardaker, M. Belvisi, 2005, American journal of respiratory and critical care medicine.

Non-Adrenergic Non-Cholinergic Neurotransmission in the Airways: Role of Nitric Oxide

M. Belvisi, A. Gibson, 2000 .

Nitric Oxide in Pulmonary Processes

M. Belvisi, 2000, Respiratory Pharmacology and Pharmacotherapy.

Soft steroids: a new approach to the treatment of inflammatory airways diseases.

M. Belvisi, D. Hele, 2003, Pulmonary pharmacology & therapeutics.

Protein Phosphatase 2A Reduces Cigarette Smoke-Induced Cathepsin S and Loss of Lung Function.

M. Belvisi, M. Ohlmeyer, A. Dabo, 2019, American journal of respiratory and critical care medicine.

The emerging role of transient receptor potential channels in chronic lung disease

M. Belvisi, M. Birrell, 2017, European Respiratory Journal.

Characterisation of a murine model of the late asthmatic response

M. Belvisi, M. Birrell, Katie E. Baker, 2017, Respiratory Research.

The discovery of RPR 200765A, a p38 MAP kinase inhibitor displaying a good oral anti-arthritic efficacy.

I. McLay, S. Phipps, M. Belvisi, 2001, Bioorganic & medicinal chemistry.

The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs?

M. Belvisi, K. Bottomley, 2003, Inflammation Research.

IκB Kinase-2-Independent and -Dependent Inflammation in Airway Disease Models: Relevance of IKK-2 Inhibition to the Clinic

M. Belvisi, M. Birrell, S. Haj‐Yahia, 2006, Molecular Pharmacology.

Transient receptor potential A1 channels: insights into cough and airway inflammatory disease.

M. Belvisi, M. Birrell, E. Dubuis, 2011, Chest.

Transient receptor potential (TRP) channels in the airway: role in airway disease

M. Belvisi, M. Birrell, E. Dubuis, 2014, British journal of pharmacology.

TNFα and IFNγ synergistically enhance transcriptional activation of CXCL10 in human airway smooth muscle cells via STAT-1, NF-κB, and the transcriptional coactivator CREB-binding protein.

M. Belvisi, D. Proud, A. Knox, 2010, The Journal of biological chemistry.

Overview of the innervation of the lung.

M. Belvisi, 2002, Current opinion in pharmacology.

Sensory nerves and airway inflammation: role of Aδ and C-fibres

M. Belvisi, 2003 .

Advances in TRP channel drug discovery: from target validation to clinical studies

M. Belvisi, R. Gaudet, A. Szallasi, 2021, Nature reviews. Drug discovery.

Distribution of human i-NANC bronchodilator and nitric oxide-immunoreactive nerves.

M. Yacoub, J. Polak, P. Barnes, 1995, American journal of respiratory cell and molecular biology.

The role of MMP-9 and MMP-12 inhibitors in inflammation

C. Bertrand, M. Belvisi, M. Birrell, 2010 .

Nitric oxide and lung disease.

P. Barnes, M. Belvisi, P. Barnes, 1993, Thorax.

Pre-clinical studies in cough research: Role of Transient Receptor Potential (TRP) channels

M. Belvisi, M. Birrell, E. Dubuis, 2013, Pulmonary pharmacology & therapeutics.

Chapter 21. Matrix metalloproteinases and the potential therapeutic role for matrix metalloproteinase inhibitors in chronic obstructive pulmonary disease(COPD)

M. Belvisi, K. Bottomley, 2002 .

CYCLO-OXYGENASE. AUTHOR'S REPLY

S. Holgate, K. Austen, M. Belvisi, 1998 .

Steroid-resistant inflammation in a rat model of chronic obstructive pulmonary disease is associated with a lack of nuclear factor-kappaB pathway activation.

M. Belvisi, M. Birrell, E. Hardaker, 2005, American journal of respiratory and critical care medicine.

Role of p38 MAP kinase in LPS‐induced airway inflammation in the rat

M. Belvisi, M. Birrell, M. Foster, 2001, British journal of pharmacology.

Effect of the p38 kinase inhibitor, SB 203580, on sephadex induced airway inflammation in the rat.

M. Belvisi, M. Birrell, M. Foster, 2000, The European respiratory journal.

Induction of eotaxin expression and release from human airway smooth muscle cells by IL‐1β and TNFα: effects of IL‐10 and corticosteroids

J. Mitchell, M. Belvisi, P. Jose, 1999 .

Cough and airway disease: The role of ion channels.

M. Belvisi, S. Bonvini, Maria G Belvisi, 2017, Pulmonary pharmacology & therapeutics.

Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation.

M. Belvisi, M. Birrell, D. Hele, 2006, European journal of pharmacology.

Back to the future: re-establishing guinea pig in vivo asthma models.

G. Nilsson, S. Dahlén, M. Belvisi, 2020, Clinical science.

Role of Matrix Metalloproteinases in the Inflammatory Response in Human Airway Cell-Based Assays and in Rodent Models of Airway Disease

M. Belvisi, M. Birrell, S. Haj‐Yahia, 2006, Journal of Pharmacology and Experimental Therapeutics.

Cough : An overview 2

M. Belvisi, M. Birrell, E. Dubuis, 2017 .

Tobacco Smoke Induced Cough: Mechanisms Driving Acute and Chronic Cough Pathology

M. Belvisi, M. Birrell, E. Dubuis, 2011 .

ERS guidelines on the assessment of cough

S. Birring, A. Morice, K. Chung, 2007, European Respiratory Journal.

Nitric oxide and lung disease Vasodilator Cytokines Steroids Cytokine W receptor

P. Barnes, M. Belvisi, 2004 .

Respiratory Infections Cause the Release of Extracellular Vesicles: Implications in Exacerbation of Asthma/COPD

Christopher S. Stevenson, C. Stevenson, M. Belvisi, 2014, PloS one.

Modulation of cholinergic contraction by cathinone: beneficial effects in airway diseases

M. Belvisi, I. Murray-Lyon, M. Birrell, 2015 .

Modulation of cholinergic contractions of airway smooth muscle by cathinone: potential beneficial effects in airway diseases

M. Belvisi, I. Murray-Lyon, M. Birrell, 2008, European Respiratory Journal.

Airway sensory innervation as a target for novel therapies: an outdated concept?

M. Belvisi, 2003, Current opinion in pharmacology.

Downregulation of MicroRNA-126 Augments DNA Damage Response in Cigarette Smokers and COPD Patients.

M. Mayr, A. Zampetaki, P. Barnes, 2017 .

Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease

J. Mitchell, M. Belvisi, 2009, British journal of pharmacology.

Inhalation of a radioactively labeled monodisperse aerosol in rats for the assessment of regional deposition and clearance.

M. Belvisi, G. Tarroni, P. Bassi, 1980, American Industrial Hygiene Association journal.

Inhibitory Nonadrenergic, Noncholinergic Innervation of Airways Smooth Muscle: Role of Nitric Oxide

M. Belvisi, T. Bai, 1994 .

He diffusion MRI 3 hyperpolarized of lung microstructure with

D. Shaw, A. Sukstanskii, D. Yablonskiy, 2015 .

Sensory nerves and airway inflammation: role of A delta and C-fibres.

M. Belvisi, 2003, Pulmonary pharmacology & therapeutics.

Anti-in ﬂ ammatory effects of PGE 2 in the lung: role of the EP 4 receptor subtype

M. Belvisi, M. Birrell, Victoria C Jones, 2015 .

Cough • 7: Current and future drugs for the treatment of chronic cough

M. Belvisi, P. Geppetti, 2004, Thorax.

afferents in Brown Norway rats Ovalbumin sensitizes vagal pulmonary C-fiber

P. O'Byrne, M. Belvisi, M. Grace, 2015 .

Nitric Oxide and Peripheral Neurotransmission in the Lung

M. Belvisi, 2000 .

Nitric oxide as a neurotransmitter in human airways.

P. Barnes, M. Belvisi, J. Mitchell, 1995, Archives internationales de pharmacodynamie et de therapie.

Transient receptor potential cation channel, subfamily V, member 4 and airway sensory afferent activation: Role of adenosine triphosphate

J. Smith, A. Ford, M. Belvisi, 2016, The Journal of allergy and clinical immunology.

Drugs Affecting TRP Channels.

M. Belvisi, M. Birrell, M. Wortley, 2017, Handbook of experimental pharmacology.

Bronchial Epithelial Cell-Derived Prostaglandin E2 Dampens the Reactivity of Dendritic Cells

D. Tsikas, F. Lasitschka, M. Belvisi, 2011, The Journal of Immunology.

Peroxisome proliferator-activated receptors as novel targets in lung disease.

M. Belvisi, D. Hele, 2008, Chest.

Theobromine inhibits sensory nerve activation and cough

O. Usmani, P. Barnes, M. Korbonits, 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Human tissue models for a human disease: what are the barriers?

S. Dahlén, M. Belvisi, A. Holmes, 2015, Thorax.

Activation of TRPV4 causes bronchoconstriction: A possible role in respiratory disease?

M. Belvisi, S. Bonvini, M. Birrell, 2013 .

The Role Of Transient Receptor Potential Vanilloid 1 (TRPV1) In Tobacco Smoke Induced Airway Inflammation

M. Belvisi, M. Birrell, M. Baxter, 2012, ATS 2012.

A Role For Airway Sensory Nerves In The Allergen Induced Late Asthmatic Response In A Rat Model Of Allergic Asthma

M. Belvisi, M. Birrell, J. Alba, 2010, Asian Test Symposium.

Multiomics links global surfactant dysregulation with airflow obstruction and emphysema in COPD

Ashley I Heinson, R. Chaerkady, D. Muthas, 2022, ERJ Open Research.

Cigarette Smoke Induced Airway Inflammation Is Independent of NF-κB Signalling

Christopher S. Stevenson, I. Adcock, T. Lawrence, 2013, PloS one.

The diagnosis and management of chronic cough

A. Morice, J. Widdicombe, J. Kastelik, 2004, European Respiratory Journal.

Estrogen Receptor β: Expression Profile and Possible Anti-Inflammatory Role in Disease

M. Belvisi, S. Farrow, M. Birrell, 2008 .

RESEARCH PAPER Role of EP 2 and EP 4 receptors in airway microvascular leak induced by prostaglandin E 2

Stephen R. Clark, M. Belvisi, M. Birrell, 2022 .

XEN-D0501, a novel TRPV1 antagonist, does not reduce cough in refractory cough patients

Michael Wortley, Lorcan McGarvey, J. Smith, 2017 .

XEN-D0501, a Novel Transient Receptor Potential Vanilloid 1 Antagonist, Does Not Reduce Cough in Patients with Refractory Cough.

J. Smith, M. Belvisi, L. Mcgarvey, 2017, American journal of respiratory and critical care medicine.

Biodiesel: is it any safer to use?

T. Sandström, M. Belvisi, T. Tetley, 2018, Occupational and Environmental Health.

CYCLOOXYGENASE-2 EXPRESSION IN AIRWAY CELLS

J. Mitchell, P. Barnes, M. Belvisi, 1998 .

DNA damage response at telomeres contributes to lung aging and chronic obstructive pulmonary disease

M. Belvisi, Clara Correia-Melo, M. Birrell, 2015, American journal of physiology. Lung cellular and molecular physiology.

Modulation of sensory nerve function and the cough reflex: understanding disease pathogenesis.

M. Belvisi, J. Nasra, 2009, Pharmacology & therapeutics.

Utility of exhaled nitric oxide as a noninvasive biomarker of lung inflammation in a disease model

M. Belvisi, M. Birrell, R. Knowles, 2006, European Respiratory Journal.

CALL FOR PAPERS Biomarkers in Lung Diseases: from Pathogenesis to Prediction to New Therapies DNA damage response at telomeres contributes to lung aging and chronic obstructive pulmonary disease

M. Belvisi, Clara Correia-Melo, M. Birrell, 2015 .

Inhibitory activity of the novel CB2 receptor agonist, GW833972A, on guinea‐pig and human sensory nerve function in the airways

M. Belvisi, M. Birrell, N. Crispino, 2008, British journal of pharmacology.

The role of CRAC channel in asthma.

Dave Singh, M. Belvisi, M. Birrell, 2015, Pulmonary Pharmacology & Therapeutics.

Barriers to new drug development in respiratory disease

S. Bonini, W. Seeger, P. Barnes, 2015, European Respiratory Journal.

Prostaglandin E2 mediates cough via the EP3 receptor: implications for future disease therapy.

M. Belvisi, M. Birrell, Sarah A. Maher, 2009, American journal of respiratory and critical care medicine.

Estrogen Receptor β: Expression Profile and Possible Anti-Inflammatory Role in Disease

M. Belvisi, M. Birrell, S. Haj‐Yahia, 2008, Journal of Pharmacology and Experimental Therapeutics.

The Arctic Council

M. Belvisi, M. Birrell, S. Moschos, 1997, Environmental Health Perspectives.

Transient receptor potential A1 channels: insights into cough and airway inflammatory disease.

M. Belvisi, M. Birrell, E. Dubuis, 2011, Chest.